Lauren E. Colbert
www.mdanderson.org
0000-0001-5806-4339
University of Texas MD Anderson Cancer Center
131 papers found
Refreshing results…
Chromodomain Helicase DNA Binding Protein 5 (CHD5) Is Associated With Improved Overall Survival in Patients Undergoing Adjuvant Therapy for Resected Pancreatic Adenocarcinoma
Chromodomain-Helicase-DNA-Binding Protein 7 (CHD7), a Novel Gemcitabine Sensitivity Gene, Is a Prognostic Biomarker in Patients With Early-Stage Resected Pancreatic Adenocarcinoma
Pronecrotic Mixed Lineage Kinase Domain-Like (MLKL) Protein Expression Is a Prognostic Biomarker in Patients With Resected Pancreatic Adenocarcinoma
Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate
Pronecrotic Mixed Lineage Kinase Domain-Like Protein Expression Is a Prognostic Biomarker in Patients With Early-Stage Resected Pancreatic Adenocarcinoma
Tumor Size on Abdominal MRI Versus Pathologic Specimen in Resected Pancreatic Adenocarcinoma: Implications for Radiation Treatment Planning
The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma
Abstract LB-168: A pilot clinical trial of chromodomain-helicase-DNA-binding protein 7 (CHD7) expression as a prognostic and predictive biomarker in patients with early-stage pancreatic adenocarcinoma.
Radiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base: A multi-institutional comparative analysis.
Tumor Size on Abdominal MRI Versus Pathologic Specimen in Resected Pancreatic Adenocarcinoma: Implications for Radiation Therapy Planning
Influence of Adjuvant Radiation Therapy Dose and Fraction on Overall Survival for Pancreatic Adenocarcinoma
Missing publications? Search for publications with a matching author name.